Evaluation of procollagen III peptide as a marker of tissue hyperthyroidism in long-term treated women with TSH suppressive doses of thyroxine

Experimental and Clinical Endocrinology and Diabetes

Volumn 107, Issue 3, 1999, Pages 190-194

  Zulewski, Henryk ^a   Siggelkow, H ^b   Walden, C ^b   Becker, W ^b   Hufner M ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

Hyperthyroidism; Procollagen III peptide; Thyroxine treatment; TSH suppression

Indexed keywords

COLLAGEN TYPE 3; LIOTHYRONINE; MARKER; PROCOLLAGEN; SEX HORMONE BINDING GLOBULIN; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CLINICAL TRIAL; FEMALE; FREE THYROXINE INDEX; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; LONG TERM CARE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL;

EID: 0032966862     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1212096     Document Type: Article

References (17)

1. Anderson DC. Sex-hormone-binding globulin. Clin Endocrinol, 3: 69-96, 1974
2. Biondi B, Fazio S, Carella C, Carella C, Amato G, Cittadini A, Lupoli G, Sacca L, Bellastella A, Lombardi G. Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab, 77: 334-338, 1993
3. Crooks J, Murray IPC, Wayne EJ. Statistical methods applied to the diagnosis of thyrotoxicosis. Q J Med, 28: 211-234, 1959
4. Faber J, Horslev-Peterson K, Perrild H, Lorenzen I. Different effects of thyroid disease on serum procollagen III N-peptide and hyaluronic acid. J Clin Endocrinol Metab, 71: 1016-1021, 1990
5. Faber J, Perrild H, Johansen JS. Bone Gla protein and sex-hormone-binding globulin in nontoxic goiter: parameters for metabolic status at the tissue level. J Clin Endocrinol Metab, 70: 49-55, 1990
6. Földes J, Tarjan G, Banos CS, Nemeth J, Varga F, Büki B. Biologic markers in blood reflecting thyroid hormone effect at peripheral tissue level in patients receiving levothyroxine replacement for hypothyroidism. Exp Clinical Endocrinol, 99: 129-133, 1992.
7. Forfar JC, Miller HC, Toft AD. Occult thyrotoxicosis: a correctable cause of idiopathic atrial fibrillation. Am J Cardiol, 44: 9-12, 1979
8. Harris A, Benedict F. A biometric study of basal metabolism in man. Washington, Carnegie Institute, 279: 40-44, 1919
9. Kucharz EJ, Jurecka-Tuleja B, Jonderko G, Marcisz C. Serum amino-terminal propeptide of type III collagen in patients with hyperthyroidism or hypothyroidism during therapy. Thyroid, 4(2): 191-194, 1994
10. Nyström E, Caidahl K, Fager G, Wikkelsö C, Lundberg P-A, Lindstedt G. A double-blind cross-over 12-months study of L-Thyroxine treatment of women with "subclinical" hypothyroidism. Clin Endocrinol, 29: 63-76, 1988
11. Nyström E, Lundberg PA, Petersen K, Bengtsson C, Lindstedt. Evidence for a slow tissue adaptation to circulating thyroxine in patients with chronic L-thyroxine treatment. Clin Endocrinol, 31: 143-150, 1989
12. Prockop DJ, Kivirikko KI, Tuderman L and Guzman NA. The biosynthesis of collagen and its disorders. New Engl J Med, 301: 13-23 and 77-87, 1979
13. Prockop DJ, Kivirikko KI: Collagens: Molecular biology, diseases, and potentials for therapy. Annu Rev Biochem, 64: 403-434, 1995
14. Ross DS, Neer RM, Ridgway EC, Daniels GH. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary thyroid axis with L-thyroxine. Am J Med, 82: 1167-1170, 1987
15. Stall GM, Harris S, Sokoll LJ, Dawson-Hughes B. (1990) Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Ann Intern Med, 113: 265-269, 1990
16. Stenlof K, Sjostrom L, Fagerberg B, Nystrom E, Lindstedt G. Thyroid hormones, procollagen III peptide, body composition and basal metabolic rate in euthyroid individuals. Scand J Clin Lab Invest, 53: 793-803, 1993
17. Trivedi P, Cheeseman P, Portman B, Hegarty J, Mowat AP. Variation in serum type III procollagen peptide with age in healthy subjects and its comparative value in the assessment of disease activity in children and adults with chronic active hepatitis. Eur J Clin Invest, 15: 69-74, 1985